Page: Medicines for human use under evaluation-2026/7/31

Document: Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (26 June 2026 - 23 July 2026)-2026/7/31

Document: Start of procedure: Extension of marketing authorisation (26 June 2026 - 23 July 2026)-2026/7/31

Document: Dates of 2027 SAWP meetings and submission deadlines Scientific advice, protocol assistance, qualification of biomarkers and parallel HTACG/EMA Joint Scientific Consultation requests-2026/7/30

Document: HMPC meeting report on European Union herbal monographs, guidelines and other activities - 6-8 July 2026-2026/7/30

Document: Annex to letter of intent-2026/7/30

Document: Template - Request for accelerated assessment pursuant to Article 14(9) of Regulation (EC) No 726/2004' to be replaced by 'Briefing Note and Recommendations on a Request for Accelerated Assessment Pursuant to Article 14 (9) of Regulation (EC) No

Page: Non-clinical requirements for severely debilitating or life-threatening diseases-2026/7/30

Document: Concept paper on the development of a reflection paper on the non-clinical requirements for severely debilitating or life-threatening diseases-2026/7/30

Document: Template - Application for transfer of marketing authorisation from transferor to transferee, attachment 1 (veterinary)-2026/7/29